Focus will be on vaccine sales and pipeline news when Bavarian Nordic report is released, says bank

Attention will be paid to Bavarian Nordic's sales of the vaccines Rabipur/Rabavert and Encepur when it releases its financial report on Friday, says Danish bank Sydbank.

Photo: Philip Davali/Ritzau Scanpix

Bavarian Nordic's sales of rabies vaccines Rabipur/Rabavert and Encepur, the company's tick-borne encephalitis vaccine, could take center stage when the pharmaceutical company releases its financial report tomorrow, says the Danish bank Sydbank.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs